The dark side of the force–constraints and complications of cell therapies for stroke

J Boltze, A Arnold, P Walczak, J Jolkkonen… - Frontiers in …, 2015 - frontiersin.org
Cell therapies are increasingly recognized as a promising option to augment the limited
therapeutic arsenal available to fight ischemic stroke. During the last two decades …

Dental pulp stem cells: an attractive alternative for cell therapy in ischemic stroke

X Lan, Z Sun, C Chu, J Boltze, S Li - Frontiers in neurology, 2019 - frontiersin.org
Ischemic stroke is a major cause of disability and mortality worldwide, but effective
restorative treatments are very limited at present. Regenerative medicine research revealed …

A neurovascular-unit-on-a-chip for the evaluation of the restorative potential of stem cell therapies for ischaemic stroke

Z Lyu, J Park, KM Kim, HJ Jin, H Wu… - Nature biomedical …, 2021 - nature.com
The therapeutic efficacy of stem cells transplanted into an ischaemic brain depends primarily
on the responses of the neurovascular unit. Here, we report the development and …

Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial

DC Hess, LR Wechsler, WM Clark, SI Savitz… - The Lancet …, 2017 - thelancet.com
Background Multipotent adult progenitor cells are a bone marrow-derived, allogeneic, cell
therapy product that modulates the immune system, and represents a promising therapy for …

Adult neurogenesis in the subventricular zone and its regulation after ischemic stroke: implications for therapeutic approaches

Y Dillen, H Kemps, P Gervois, E Wolfs… - Translational stroke …, 2020 - Springer
Adult neurogenesis in the subventricular zone is a topic of intense research, since it has vast
implications for the fundamental understanding of the neurobiology of the brain and its …

Human muse cells reconstruct neuronal circuitry in subacute lacunar stroke model

H Uchida, K Niizuma, Y Kushida, S Wakao… - Stroke, 2017 - Am Heart Assoc
Background and Purpose—Multilineage-differentiating stress-enduring (muse) cells are
endogenous nontumorigenic stem cells with pluripotency harvestable as pluripotent marker …

Behavioral outcome measures to improve experimental stroke research

MG Balkaya, RC Trueman, J Boltze, D Corbett… - Behavioural brain …, 2018 - Elsevier
Functional recovery after an experimental stroke can be assessed by multiple behavioral
tests, however, there is no consensus about which test to use in long-term stroke recovery …

Allogeneic adipose-derived mesenchymal stem cell sheet that produces neurological improvement with angiogenesis and neurogenesis in a rat stroke model

B Ryu, H Sekine, J Homma, T Kobayashi… - Journal of …, 2019 - thejns.org
OBJECTIVE Stem cell therapy is a promising strategy for the treatment of severe cerebral
ischemia. However, targeting sufficient grafted cells to the affected area remains …

Stem cell transplantation for ischemic stroke

GB Boncoraglio, M Ranieri, A Bersano… - Cochrane Database …, 2019 - cochranelibrary.com
Background Stroke is a leading cause of morbidity and mortality worldwide, with very large
healthcare and social costs, and a strong demand for alternative therapeutic approaches …

Parkinson's disease: from genetics and epigenetics to treatment, a miRNA-based strategy

E Paccosi, L Proietti-De-Santis - International Journal of Molecular …, 2023 - mdpi.com
Parkinson's disease (PD) is one of the most common neurodegenerative disorders,
characterized by an initial and progressive loss of dopaminergic neurons of the substantia …